Nalaganje...
Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation
Cystic fibrosis (CF) is a life-shortening disease caused by the mutations that generate nonfunctional CF transmembrane conductance regulator (CFTR) protein. A rare serine-to-tyrosine (S1045Y) CFTR mutation was earlier reported to result in CF-associated fatality. We identified an African-American pa...
Shranjeno v:
| izdano v: | Am J Physiol Lung Cell Mol Physiol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Physiological Society
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5142455/ https://ncbi.nlm.nih.gov/pubmed/27261451 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajplung.00134.2016 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|